Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Susanne Clara Bard, UC San Diego Beyond the widespread attention GLP-1 drugs are receiving for treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease, emerging research is investigating their other potential impacts including their effects on aging
Always follow local guidelines before purchasing research materials
Studies suggest it may interact with hormone-related receptors, potentially affecting glucose utilization, appetite-related signals, and energy expenditure in controlled environments
For instance, while GLP-1 agonists are primarily metabolised by the kidneys and have a low potential for significant drug-drug interactions, it is still important to monitor patients closely when combining therapies
US$ 27.95
US$ 24.74
US$ 21.24
US$ 27.72
US$ 20.01
US$ 29.08
